Inhaled colistimethate sodium in patients with bronchiectasis and Pseudomonas aeruginosa infection: results of PROMIS-I and PROMIS-II, two randomised, double-blind, placebo-controlled phase 3 trials assessing safety and efficacy over 12 months-Reference-Cited by-同舟云学术

Inhaled colistimethate sodium in patients with bronchiectasis and Pseudomonas aeruginosa infection: results of PROMIS-I and PROMIS-II, two randomised, double-blind, placebo-controlled phase 3 trials assessing safety and efficacy over 12 months

Published:2024-09 Issue: Volume: Page:
ISSN:2213-2600
Container-title:The Lancet Respiratory Medicine
language:en
Short-container-title:The Lancet Respiratory Medicine

Author:

Haworth Charles S,Shteinberg Michal,Winthrop Kevin,Barker Alan,Blasi Francesco,Dimakou Katerina,Morgan Lucy C,O'Donnell Anne E,Ringshausen Felix C,Sibila Oriol,Thomson Rachel M,Carroll Kevin J,Pontenani Federica,Castellani Paola,Chalmers James D

Publisher

Elsevier BV

Reference34 articles.

1. A comprehensive analysis of the impact of Pseudomonas aeruginosa colonization on prognosis in adult bronchiectasis;Finch;Ann Am Thorac Soc,2015

2. Short- and long-term antibiotic treatment reduces airway and systemic inflammation in non-cystic fibrosis bronchiectasis;Chalmers;Am J Respir Crit Care Med,2012

3. European Respiratory Society guidelines for the management of adult bronchiectasis;Polverino;Eur Respir J,2017

4. Bronchiectasis in Europe: data on disease characteristics from the European Bronchiectasis registry (EMBARC);Chalmers;Lancet Respir Med,2023

5. Clinical outcomes of bronchiectasis in India: data from the EMBARC/Respiratory Research Network of India registry;Dhar;Eur Respir J,2023

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PROMISing results for inhaled antibiotics in bronchiectasis;The Lancet Respiratory Medicine;2024-09